FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

48988008: Alprostadil (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
81612010 Alprostadil en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1230669010 Prostaglandin E1 en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2989117017 Prostaglandin PGE1 en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3664627018 Alprostadil (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
81611015 Prostaglandin PGE>1< en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
81612010 Alprostadil en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
81612010 Alprostadil en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
81612010 Alprostadil en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
786616018 Prostaglandin PGE>1< (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1230669010 Prostaglandin E1 en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1230670011 PGE1 - Prostaglandin E1 en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1230670011 PGE1 - Prostaglandin E1 en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
2579409012 Prostaglandin E>1< en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2671294013 Alprostadil - chemical en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2671294013 Alprostadil - chemical en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
2988971016 Prostaglandin PGE1 (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2989117017 Prostaglandin PGE1 en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3664627018 Alprostadil (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
52821000195113 alprostadil it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
67691000195117 Alprostadil de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1117861000241116 alprostadil fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1117871000241112 prostaglandine E1 fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1118271000241114 PGE1 - prostaglandine E1 fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1117861000241116 alprostadil fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1117871000241112 prostaglandine E1 fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1118271000241114 PGE1 - prostaglandine E1 fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
52821000195113 alprostadil it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
67691000195117 Alprostadil de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prostaglandin E1 Is a Prostaglandin false Inferred relationship Existential restriction modifier (core metadata concept)
Prostaglandin E1 Is a Prostaglandin group E (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Prostaglandin E1 measurement (procedure) Has measured component False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Prostaglandin E1 measurement (procedure) Component True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil Is a False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Prostaglandin E>1< preparation (substance) Is a False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Prostaglandin E>1< preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Dinoprostone 10mg pessary (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dinoprostone 500 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Dinoprostone 5mg/0.5mL extra-amniotic solution+diluent (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Dinoprostone 400 microgram/mL vaginal gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Dinoprostone 3 mg vaginal tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Product containing gemeprost (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely gemeprost 1 milligram/1 each conventional release vaginal pessary (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Oral dinoprostone (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Dinoprostone-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Product containing dinoprostone in vaginal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Product containing dinoprostone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Dinoprostone 10mg insert The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Product containing alprostadil in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 40.0mcg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 500micrograms pellet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 20.2mcg/mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 1000micrograms pellet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 500mcg injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 5micrograms injection (pdr for recon)+diluent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil adverse reaction Causative agent (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 40micrograms injection (pdr for recon)+diluent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 40micrograms injection cartridge continuation pack The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 10micrograms injection cartridge continuation pack (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
alprostadil 20micrograms injection cartridge starter pack The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
alprostadil 500 microgrammes/mL, ampoule de 1 mL de concentré pour perfusion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
alprostadil 10micrograms injection cartridge starter pack The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 10.16mcg/mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
alprostadil 40micrograms injection cartridge starter pack The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Allergy to alprostadil (finding) Causative agent (attribute) False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 125micrograms pellet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 250micrograms pellet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 20micrograms injection (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 20micrograms injection cartridge continuation pack (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 10micrograms injection (pdr for recon)+diluent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil [erectile dysfunction] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 20micrograms injection (pdr for recon)+diluent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 10micrograms injection (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 500mcg pessary The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 250mcg suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 125mcg suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 1000mcg suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 5mcg/mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
alprostadil 20micrograms cartridge syringe injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 10micrograms cartridge syringe injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Product containing alprostadil in genitourinary dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Allergy to alprostadil (finding) Causative agent (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 40micrograms powder for conventional release solution for injection cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 125 microgram urethral stick The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 250 microgram urethral stick The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil 1 mg urethral stick The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept)
Alprostadil-containing product in urethral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 10 microgram powder for solution for injection cartridge Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 10 microgram powder for solution for injection cartridge Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 10 microgram powder for solution for injection vial Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 10 microgram powder for solution for injection vial Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 20 microgram powder for solution for injection cartridge Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 20 microgram powder for solution for injection cartridge Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 20 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 20 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 40 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 40 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 5 microgram powder for solution for injection vial Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 5 microgram powder for solution for injection vial Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion ampule Has basis of strength substance (attribute) False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion ampule Has precise active ingredient False Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only alprostadil (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only alprostadil in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only alprostadil in urethral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion (clinical drug) Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion (clinical drug) Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 1 mg urethral stick Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 1 mg urethral stick Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 250 microgram urethral stick Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 250 microgram urethral stick Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 125 microgram urethral stick Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 125 microgram urethral stick Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 20 microgram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 20 microgram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 500 microgram/mL solution for injection Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 500 microgram/mL solution for injection Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 500 microgram/mL solution for infusion and/or injection Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil 500 microgram/mL solution for infusion and/or injection Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 3 milligram/1 gram conventional release cutaneous cream (clinical drug) Has precise active ingredient True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alprostadil 3 milligram/1 gram conventional release cutaneous cream (clinical drug) Has basis of strength substance (attribute) True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1
Alprostadil only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Prostaglandin E1 Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start